The Director Team at argenx is responsible for strategic oversight, guiding the company’s antibody therapeutic development, ensuring successful product launches, effective scientific communication, and maintaining competitive readiness. Comprising executive and non-executive directors, the team plays a crucial role in steering the company’s innovation pipeline and aligning it with market demands and patient needs.
Ana Cespedes
Non-Executive Director
Brian Kotzin
Director
Camilla Sylvest
Non-Executive Director
Clemence Arvin-Berod
Associate Director Pipeline HE...
Don deBethizy
Director
Elliot Carney
Director, Thought Leader Liais...
James M. Daly
Director
James Michael Daly
Director
Kristin Cuccio
Sr. Director Launch Excellence...
Pamela M. Klein
Director
Soheil Chavoshi
Sr. Director, Scientific Commu...
Steve Krognes
Director
Tony Rosenberg
Director